1. Home
  2. RVP vs SER Comparison

RVP vs SER Comparison

Compare RVP & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Retractable Technologies Inc.

RVP

Retractable Technologies Inc.

N/A

Current Price

$0.67

Market Cap

20.9M

Sector

Health Care

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

N/A

Current Price

$1.91

Market Cap

19.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVP
SER
Founded
1994
2017
Country
United States
United States
Employees
N/A
13
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
19.4M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
RVP
SER
Price
$0.67
$1.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
34.3K
78.1K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$38,266,211.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.78
N/A
52 Week Low
$0.60
$1.22
52 Week High
$1.14
$7.92

Technical Indicators

Market Signals
Indicator
RVP
SER
Relative Strength Index (RSI) 46.68 54.91
Support Level $0.62 $1.75
Resistance Level $0.74 $1.96
Average True Range (ATR) 0.03 0.15
MACD -0.00 0.01
Stochastic Oscillator 20.00 63.24

Price Performance

Historical Comparison
RVP
SER

About RVP Retractable Technologies Inc.

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: